DOI:
10.1055/s-00029030
Journal of Pediatric Neurology
LinksClose Window
References
French JA, Lawson JA, Yapici Z. et al.
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
Lancet 2016;
388 (10056): 2153-2163
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.